|
Volumn 32, Issue 7, 2005, Pages 977-981
|
A Phase I study of docetaxel and cisplatin for advanced squamous cell carcinoma of the head and neck
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOCETAXEL;
TAXOID;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
FEMALE;
HEAD AND NECK TUMOR;
HUMAN;
LUNG TUMOR;
MALE;
MAXIMUM TOLERATED DOSE;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
SQUAMOUS CELL CARCINOMA;
TUMOR RECURRENCE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HEAD AND NECK NEOPLASMS;
HUMANS;
LUNG NEOPLASMS;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
TAXOIDS;
|
EID: 22844447760
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|